AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
Stocks of AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories rose after New York Federal Reserve President John Williams hinted at a potential interest rate cut. This increased the likelihood of a rate cut at the December meeting from 39% to over 73%, boosting market sentiment. AbbVie rose 3.4%, Biogen 4.1%, BioMarin 3.5%, DexCom 3.9%, and Abbott Laboratories 3.6%. The market's reaction highlights the impact of macroeconomic signals on stock prices.
Stock Story·